Low-dose cytosine arabinoside in the treatment of acute nonlymphoblastic leukemia and myelodysplastic syndromes.
D000208:Acute Disease; D000328:Adult; D000368:Aged; D001853:Bone Marrow / Q000473:pathology; D001855:Bone Marrow Diseases / Q000188:drug therapy* / Q000473:pathology; D002478:Cells, Cultured; D003561:Cytarabine / Q000008:administration & dosage* / Q000627:therapeutic use; D006098:Granulocytes / Q000473:pathology; D006410:Hematopoiesis; D006801:Humans; D007938:Leukemia / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D013577:Syndrome
D003561:Cytarabine